Effect of prostaglandin E1 (PGE1) and sildenafil on serotonin metabolism and some oxidative damage markers in rat prostate gland and brain

Andrologia

Volumn 43, Issue 4, 2011, Pages 266-272

  Guzman D C ^a   Olguin H J ^b   Brizuela, N O ^a   Garcia E H ^b   Mejia G B ^a   Jacobo, A J ^a   Abarca, L S ^a   Betancourt, E T ^c  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Brain; Erectile dysfunction; Prostate; Sildenafil; Testosterone

Indexed keywords

ADENOSINE TRIPHOSPHATASE; FREE RADICAL; GLUTATHIONE; POTASSIUM ION; PROSTAGLANDIN E1; SEROTONIN; SILDENAFIL; SODIUM ION; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; LIPID BRAIN LEVEL; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROSTATE; RAT; SEROTONIN METABOLISM; SINGLE DRUG DOSE; TESTOSTERONE BLOOD LEVEL;

ALPROSTADIL; ANIMALS; BRAIN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PIPERAZINES; PROSTATE; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SODIUM-POTASSIUM-EXCHANGING ATPASE; SULFONES; TESTOSTERONE;

EID: 79960022363     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2010.01067.x     Document Type: Article

References (39)

1. Arkhipenko Y, Meerson FZ, Sazontova TG, Kagan VE (1985) Mode of lipid peroxidation-induced inhibition of Na, K-ATPase. Acta Physiol Pharmacol Bulg 11:70-78.
2. Benuck M, Banay-Schwartz M, DeGuzman T, Lajtha A (1995) Effect of food deprivation on glutathione and amino acid levels in brain and liver of young and aged rats. Brain Res 678:259-264.
3. Borsick M, Taub M (2006) Evidence for post-transcriptional regulation of Na, K-ATPase by prostaglandin E1. Biochem Biophys Res Commun 345:739-745.
4. Bougoulia M, Triantos A, Koliakos G (2006) Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormone 5:259-269.
5. Calderon GD, Toledo LA, Hernandez IJ, Barragán MG, Rodríguez PR, Hernandez GE (2001) Determinación de triptófano en cerebro de ratas expuestas a ozono. Arch Neurosci (Mex) 6:2-5.
6. +-ATPase in adult rat brain. Neurochem Res 5:619-624.
7. Castilla-Serna L (1999) Estadística Simplificada Para la Investigación en Ciencias de la Salud. Editorial Trillas. 2 Edición. Editorial Trillas, first edition, México, D.F.
8. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689-695.
9. Fiske CH, Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66:375-400.
10. Fujita N (1993) Prostaglandin E1-induced hypotension: its effect on rate of cerebrospinal fluid formation in anesthetized cats. J Osaka Dent Univ 27:67-76.
11. Giuliano F, Montorsi F, Mirone V, Rossi D, Sweeney M (2000) Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group. J Urol 164:708-711.
12. Gutteridge JM, Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135.
13. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ (2001) Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 50:241-247.
14. Hissin PJ, Hif R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissue. Anal Biochem 74:214-226.
15. Kaehler ST, Singewald N, Sinner C, Philippu A (1999) Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res 835:346-349.
16. Kaplan JH (2002) Biochemistry of Na, K-ATPase. Annu Rev Biochem 71:511-535.
17. Kikuchi S, Shinpo K, Niino M, Tsuji S, Iwabuchi K, Onoé K, Tashiro K (2002) Prostaglandin E1 protects cultured spinal neurons against the effects of nitric oxide toxicity. Neuropharmacology 43:714-723.
18. Koupparis AJ, Jeremy JY, Muzaffar S, Persad R, Shukla N (2005) Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int 96:423-427.
19. Kuhn DM, Arthur RE Jr (1996) Inactivation of brain tryptophan hydroxylase by nitric oxide. J Neurochem 67:1072-1077.
20. Levin G, Cogan U, Levy Y, Mokady S (1990) Riboflavin deficiency and the function and fluidity of rat erythrocyte membranes. J Nutr 120:857-861.
21. Milani E, Nikfar S, Khorasani R, Zamani MJ, Abdollahi M (2005) Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol C Toxicol Pharmacol 140:251-255.
22. Mobley DF, Baum N (1998) When patients request the impotence pill. Postgrad Med 104:55-58.
23. Moncada S, Bolaños JP (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97:1676-1689.
24. Morelli A, Vignozzi L, Filippi S, Mancipa R, Maggi M (2005) Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. Minerva Urol Nepfrol 57:85-90.
25. Muñoz CJR, Montilla P, Padillo FJ, Bujalance I, Muñoz MC, Muntané J (2006) Role of serotonin in cerebral oxidative stress in rats. Acta Neurobiol Exp 66:1-6.
26. Neault JF, Benkiran A, Malonga H, Tajmir-Riahi HA (2001) The effects of anions on the solution structure of Na, K-ATPase. J Biomol Struct Dyn 19:95-102.
27. Nehra A, Kulaksizoglu H (2002b) Combination therapy for erectile dysfunction: where we are and what's in the future. Curr Urol Rep 3:467-470.
28. Nehra A, Blute ML, Barret DM, Moreland RB (2002a) Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 14:S38-S42.
29. Ohnishi ST, Sakamoto A, Ohnishi T, Ogawa R (1992) Inhibition of lipid peroxidation by prostaglandin oligomeric derivatives. Prostaglandins Leukot Essent Fatty Acids 45:217-221.
30. Oliw EH, Kinn AC, Kvist U (1988) Biochemical characterization of prostaglandin 19-hydroxylase of seminal vesicles. J Biol Chem 263:7222-7227.
31. Radeck W, Kubicki A, Staib W (1988) Quantitative determination of human plasma testosterone by HPLC. Z Anal Chem 330:386.
32. Rauchová H, Drahota Z, Koudelová J (1999) The role of membrane fluidity changes and thiobarbituric acid-reactive substances production in the inhibition of cerebral cortex Na+/K+-ATPase activity. Physiol Res 48:73-78.
33. Shi H, Liu KJ (2006) Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neurosci Lett 410:57-61.
34. Sun Y (1990) Free radicals, antioxidants enzymes and carcinogenesis. Free Radic Biol Med 8:583-599.
35. Tang MX, Jacobs D, Stern Y (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer disease. Lancet 348:429-432.
36. +2-dependent ATPases activity in brain synaptosomes of aging rats. J Physiol Pharmacol 57:145-158.
37. Traish AM, Guay AT, Feeley R, Saad F (2009) The dark side of testosterone deficiency: I Metabolic syndrome and erectile dysfunction. J Androl 30:10-22.
38. Virag R (2002) Flow-dependent dilatation of the cavernous artery. A potential test of penile NO content. J Mal Vasc 27:214-217.
39. Wu F, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134:489-492.